Search

everythinglearnresearchcommunity

for

Search:↓

Different sizes of keratin peptides can strengthen hair, with smaller ones possibly increasing volume and larger ones repairing damage.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Low-dose minoxidil effectively enhances facial hair with minimal side effects.

Ultrasound and Doppler analysis are valuable tools for diagnosing and understanding polycystic ovary syndrome.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Combining probiotics, clotrimazole gel, and laser therapy improves treatment for recurrent yeast infections.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Jasmonic acid helps plants grow, defend against threats, and survive stressful conditions like drought and salt.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Human hair contains more glycosaminoglycans in children than adults, and these compounds decrease with age, possibly affecting hair thickness.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Women with PCOS often have sleep and mental health issues, especially if overweight or insulin resistant.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

The journal covered various dermatology topics, including treatments, disease management, and research findings.